GTS Securities’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,354
Closed -$831K – 1671
2026
Q1
$831K Buy
22,354
+9,161
+69% +$362K 0.03% 471
2025
Q4
$538K Buy
13,193
+106
+0.8% +$4.29K 0.02% 747
2025
Q3
$521K Sell
13,087
-3,330
-20% -$126K 0.02% 705
2025
Q2
$593K Sell
16,417
-966
-6% -$31.7K 0.03% 583
2025
Q1
$559K Buy
17,383
+447
+3% +$15.4K 0.02% 630
2024
Q4
$578K Buy
16,936
+8,065
+91% +$275K 0.03% 544
2024
Q3
$295K Buy
8,871
+847
+11% +$27.5K ﹤0.01% 3309
2024
Q2
$263K Buy
+8,024
New +$251K ﹤0.01% 3236
2024
Q1
– Sell
-21,075
Closed -$597K – 4194
2023
Q4
$597K Buy
+21,075
New +$553K ﹤0.01% 2640

Other funds holding LRND

GTS Securities's LRND Position: Q2 2026 in Review

GTS Securities sold out of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) in Q2 2026, closing a stake of 22,354 shares — an estimated $831K sold.

GTS Securities first reported a position in LRND in Q4 2023 and held it in 9 quarters. The position peaked at $831K in Q1 2026. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.

  • GTS Securities reported no remaining New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 22,354 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $831K.
  • GTS Securities first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q4 2023 and held it in 9 quarters.
  • GTS Securities's New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position peaked at $831K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.